HK1125674A1 - Rescue of influenza virus - Google Patents
Rescue of influenza virusInfo
- Publication number
- HK1125674A1 HK1125674A1 HK09104018.1A HK09104018A HK1125674A1 HK 1125674 A1 HK1125674 A1 HK 1125674A1 HK 09104018 A HK09104018 A HK 09104018A HK 1125674 A1 HK1125674 A1 HK 1125674A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- influenza
- cell
- nucleic acid
- virus
- provides
- Prior art date
Links
- 241000712461 unidentified influenza virus Species 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 229960003971 influenza vaccine Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078527 | 2004-12-24 | ||
| PCT/EP2005/057092 WO2006067211A1 (en) | 2004-12-24 | 2005-12-22 | Rescue of influenza virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1125674A1 true HK1125674A1 (en) | 2009-08-14 |
Family
ID=34928779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09104018.1A HK1125674A1 (en) | 2004-12-24 | 2009-04-30 | Rescue of influenza virus |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7959930B2 (ko) |
| EP (2) | EP2295542B1 (ko) |
| JP (2) | JP5620048B2 (ko) |
| KR (1) | KR101272487B1 (ko) |
| CN (1) | CN101379183B (ko) |
| AU (1) | AU2005318087B2 (ko) |
| BR (1) | BRPI0518568A2 (ko) |
| CA (1) | CA2592439C (ko) |
| DK (1) | DK1831357T3 (ko) |
| ES (1) | ES2395813T3 (ko) |
| HK (1) | HK1125674A1 (ko) |
| IL (1) | IL183888A (ko) |
| MX (1) | MX2007007889A (ko) |
| NO (1) | NO20073737L (ko) |
| NZ (1) | NZ556061A (ko) |
| PT (1) | PT1831357E (ko) |
| RU (2) | RU2435855C2 (ko) |
| TW (2) | TWI495724B (ko) |
| WO (1) | WO2006067211A1 (ko) |
| ZA (1) | ZA200705145B (ko) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2435180C (en) | 2001-01-19 | 2019-04-09 | Vironovative B.V. | A virus causing respiratory tract illness in susceptible mammals |
| CA2477234C (en) | 2002-02-21 | 2014-12-30 | Medimmune Vaccines, Inc. | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| BRPI0518568A2 (pt) * | 2004-12-24 | 2008-11-25 | Solvay Pharm Bv | mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico |
| US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
| WO2007002008A2 (en) | 2005-06-21 | 2007-01-04 | Medimmune Vaccines, Inc. | Methods and compositions for expressing negative-sense viral rna in canine cells |
| KR20080069232A (ko) | 2005-11-04 | 2008-07-25 | 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. | 스플리트 인플루엔자 백신에 대한 보조제로서 유리 수성상계면활성제를 갖는 에멀젼 |
| JP2009514850A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン |
| EP2368572B1 (en) | 2005-11-04 | 2020-03-04 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| NZ568211A (en) | 2005-11-04 | 2011-11-25 | Novartis Vaccines & Diagnostic | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| NZ592713A (en) | 2005-11-04 | 2012-12-21 | Novartis Vaccines & Diagnostic | Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9 |
| KR20110110853A (ko) | 2006-01-27 | 2011-10-07 | 노파르티스 파르마 아게 | 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신 |
| US20100068223A1 (en) | 2006-03-24 | 2010-03-18 | Hanno Scheffczik | Storage of Influenza Vaccines Without Refrigeration |
| AU2007245192B2 (en) | 2006-03-31 | 2012-04-12 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
| CA3016948A1 (en) | 2006-09-11 | 2008-03-20 | Seqirus UK Limited | Making influenza virus vaccines without using eggs |
| PL2121011T3 (pl) | 2006-12-06 | 2014-10-31 | Novartis Ag | Szczepionki zawierające antygeny czterech szczepów wirusa grypy |
| US9474798B2 (en) | 2007-06-18 | 2016-10-25 | Wisconsin Alumni Research Foundation | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
| EA201070066A1 (ru) | 2007-06-27 | 2010-06-30 | Новартис Аг | Вакцины против гриппа с низким содержанием добавок |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| EP2268309B1 (en) | 2008-03-18 | 2015-01-21 | Novartis AG | Improvements in preparation of influenza virus vaccine antigens |
| CA2752039A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccine regimens for pandemic-associated strains |
| WO2010092477A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccines with increased amounts of h3 antigen |
| EA201500910A1 (ru) | 2009-02-10 | 2016-04-29 | Новартис Аг | Вакцины против гриппа со сниженным количеством сквалена |
| DE102010018462A1 (de) | 2009-04-27 | 2011-04-07 | Novartis Ag | Impfstoffe zum Schutz gegen Influenza |
| EP2459722B1 (en) | 2009-07-31 | 2017-09-06 | Seqirus UK Limited | Reverse genetics systems |
| ES2813347T3 (es) | 2009-10-26 | 2021-03-23 | Wisconsin Alumni Res Found | Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero |
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| JP2013529913A (ja) * | 2010-06-02 | 2013-07-25 | アヴィール グリーン ヒルズ バイオテクノロジー リサーチ ディベロプメント トレード アクチエンゲゼルシャフト | Ｒｎａウィルスの作製のための方法及びヘルパーウィルス |
| FR2962739B1 (fr) * | 2010-07-13 | 2014-01-31 | Univ Claude Bernard Lyon | Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza |
| CA2852857A1 (en) | 2011-10-20 | 2013-04-25 | Novartis Ag | Adjuvanted influenza b virus vaccines for pediatric priming |
| GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
| US10080794B2 (en) | 2013-03-15 | 2018-09-25 | University Of Maryland, College Park | Swine influenza viruses and constructs and uses thereof |
| EP3022296B1 (en) | 2013-07-15 | 2022-12-28 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs |
| WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
| EP3307761A4 (en) | 2015-06-09 | 2019-01-16 | Sanofi Pasteur Inc. | PROCESS FOR OPTIMIZING NUCLEOTIDE SEQUENCES COPING MANIPULATED INFLUENZA PROTEINS |
| JP2018524323A (ja) | 2015-06-26 | 2018-08-30 | セキラス ユーケー リミテッド | 抗原がマッチしたインフルエンザワクチン |
| US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
| EP3764098B1 (en) | 2015-07-07 | 2022-11-16 | Seqirus UK Limited | Influenza potency assays |
| EP3417056A1 (en) | 2016-02-19 | 2018-12-26 | Wisconsin Alumni Research Foundation (WARF) | Improved influenza b virus replication for vaccine development |
| WO2020167432A2 (en) | 2019-01-23 | 2020-08-20 | Yoshihiro Kawaoka | Mutations that confer genetic stability to additional genes in influenza viruses |
| CN113874496A (zh) | 2019-02-08 | 2021-12-31 | 威斯康星校友研究基金会(Warf) | 人源化细胞系 |
| US11390649B2 (en) | 2019-05-01 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
| EP4022046A2 (en) | 2019-08-27 | 2022-07-06 | Wisconsin Alumni Research Foundation (WARF) | Recombinant influenza viruses with stabilized ha for replication in eggs |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166057A (en) * | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
| US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
| US6001634A (en) | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
| US6887699B1 (en) | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
| US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
| US8715940B2 (en) * | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| DK1185615T3 (da) | 1999-04-06 | 2007-11-05 | Wisconsin Alumni Res Found | Rekombinante influenzavirus til vacciner og genterapi |
| ATE353370T1 (de) | 1999-07-14 | 2007-02-15 | Sinai School Medicine | In vitro-rekonstitution von segmentierten, negativstrang-rna-viren |
| JP2003506039A (ja) * | 1999-08-02 | 2003-02-18 | ワイス | ｃＤＮＡからの流行性耳下腺炎ウイルスのレスキュー |
| US6764685B1 (en) * | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| SI1317559T1 (sl) | 2000-04-28 | 2009-04-30 | St Jude Childrens Res Hospital | Sistem transfekcije dna za pripravo infektivne negativne verige virusne rna |
| KR20030013451A (ko) * | 2000-06-23 | 2003-02-14 | 아메리칸사이아나미드컴파니 | 인플루엔자 에이/유돈/72(에이치3엔2) 게놈의뉴클레오타이드 서열 |
| CA2477234C (en) * | 2002-02-21 | 2014-12-30 | Medimmune Vaccines, Inc. | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| DK1499348T3 (en) * | 2002-04-26 | 2015-01-05 | Medimmune Llc | PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE |
| US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
| BRPI0518568A2 (pt) * | 2004-12-24 | 2008-11-25 | Solvay Pharm Bv | mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico |
-
2005
- 2005-12-22 BR BRPI0518568-8A patent/BRPI0518568A2/pt not_active IP Right Cessation
- 2005-12-22 AU AU2005318087A patent/AU2005318087B2/en not_active Ceased
- 2005-12-22 DK DK05825287.5T patent/DK1831357T3/da active
- 2005-12-22 CA CA2592439A patent/CA2592439C/en not_active Expired - Fee Related
- 2005-12-22 WO PCT/EP2005/057092 patent/WO2006067211A1/en active Application Filing
- 2005-12-22 JP JP2007547535A patent/JP5620048B2/ja not_active Expired - Fee Related
- 2005-12-22 EP EP10182258A patent/EP2295542B1/en not_active Not-in-force
- 2005-12-22 US US11/722,769 patent/US7959930B2/en not_active Expired - Fee Related
- 2005-12-22 PT PT58252875T patent/PT1831357E/pt unknown
- 2005-12-22 RU RU2007128336/10A patent/RU2435855C2/ru not_active IP Right Cessation
- 2005-12-22 NZ NZ556061A patent/NZ556061A/en not_active IP Right Cessation
- 2005-12-22 ES ES05825287T patent/ES2395813T3/es active Active
- 2005-12-22 CN CN2005800447512A patent/CN101379183B/zh not_active Expired - Fee Related
- 2005-12-22 MX MX2007007889A patent/MX2007007889A/es active IP Right Grant
- 2005-12-22 EP EP05825287A patent/EP1831357B1/en active Active
- 2005-12-22 KR KR1020077017093A patent/KR101272487B1/ko not_active IP Right Cessation
- 2005-12-23 TW TW101113590A patent/TWI495724B/zh not_active IP Right Cessation
- 2005-12-23 TW TW094146438A patent/TWI402344B/zh not_active IP Right Cessation
-
2007
- 2007-06-13 IL IL183888A patent/IL183888A/en not_active IP Right Cessation
- 2007-06-21 ZA ZA200705145A patent/ZA200705145B/xx unknown
- 2007-07-18 NO NO20073737A patent/NO20073737L/no not_active Application Discontinuation
-
2009
- 2009-04-30 HK HK09104018.1A patent/HK1125674A1/xx not_active IP Right Cessation
-
2011
- 2011-04-15 US US13/088,120 patent/US20120156241A1/en not_active Abandoned
- 2011-05-31 RU RU2011122117/10A patent/RU2011122117A/ru not_active Application Discontinuation
-
2012
- 2012-03-22 JP JP2012065345A patent/JP5702321B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1125674A1 (en) | Rescue of influenza virus | |
| Rauch et al. | New vaccine technologies to combat outbreak situations | |
| Chen et al. | Advances in development and application of influenza vaccines | |
| CN1826407B (zh) | 用于疫苗和基因治疗的高滴度重组流感病毒 | |
| EP2010557B1 (en) | High titer recombinant influenza viruses for vaccines | |
| WO2003072720A3 (en) | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus | |
| HK1207828A1 (en) | Cell-derived viral vaccines with low levels of residual cell dna dna | |
| Le Nouën et al. | Attenuation of human respiratory viruses by synonymous genome recoding | |
| AU2012204138B2 (en) | High titer recombinant influenza viruses for vaccines | |
| BRPI0922867B8 (pt) | glicoproteina de fusão (f) de vírus sincicial respiratório (rsv), ácido nucleico isolado, célula hospedeira, composição de vacina e micela purificada | |
| HK1159188A1 (zh) | 重組的新城疫病毒 表達系統及疫苗 | |
| HU229101B1 (en) | Dna transfection system for the generation of infectious influenza virus | |
| ATE434035T1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
| WO2005027825A3 (en) | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus | |
| UA85371C2 (ru) | Модифицированный вирус коровьей оспы ankara для вакцинации новорожденных | |
| EP2527445A3 (en) | Treatment and prevention of influenza | |
| ATE369435T1 (de) | Paramyxoviren, die eine modifizierte transkriptionsstartsequenz umfassen | |
| AU2014202470A1 (en) | High titer recombinant influenza viruses for vaccines | |
| WO2006045532A3 (en) | Virosome particles comprising antigens from influenza virus and hepatitis b virus | |
| JP2005245302A (ja) | 組換えインフルエンザウイルスおよびそれを用いたワクチン | |
| WO2008024413A3 (en) | Tissue culture system for production of hepatitis c virus | |
| CN102875660B (zh) | 一种病毒诱导蛋白Mig1及其应用 | |
| RU2020136260A (ru) | Живой аттенуированный штамм вируса желтой лихорадки, адаптированный к росту в клетках vero, и вакцинная композиция, содержащая его | |
| Campbell | Vaccines for equine influenza | |
| TH110151B (th) | "กรรมวิธีการผลิตไวรัสสังเคราะห์ชนิดที่ดัดแปลงยีนเฉพาะตำแหน่งและยีนสังเคราะห์ที่ดัดแปลงแล้ว" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171222 |